Wyeth Pharmaceuticals, a division of Wyeth and Progenics Pharmaceuticals have received a positive opinion for Relistor subcutaneous injection from the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency.

Neurochem has reported that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has issued a negative opinion recommending refusal of the marketing authorization application for eprodisate, for the treatment of Amyloid A amyloidosis.

By Albrecht, Uwe Goos, Karl-Heinz; Schneider, Bert